There is no direct evidence that IGF-1 peptides cause cancer, but because IGF-1 promotes cellular proliferation , individuals with a history of cancer or pre-cancerous conditions should avoid use unless under medical supervision
therefore, drugs targeting EPHB1, PI3K/AKT, and Bcl-2/Bcl-xL, which are involved in the apoptosis resistance pathway, have been developed 28
Several groups and generations of antibiotics have been discovered and developed with specific target mechanisms of action on bacterial cells (Kapoor et al., 2017
Most patients report body aches lasting 2-4 weeks, typically appearing during dose escalation or the first month of therapy
They have presented significant potential in treating several disorders of the skin including, melanoma, acne, hair loss, and skin whitening [126128]